EZZ Life Science Holdings
EZZ Life Science Holdings (ASX: EZZ) is an Australian genomic life sciences company that develops, produces, and distributes consumer health supplements and wellness products under the EZZ, MeTime, and EZZDAY brands across Australia, China, Southeast Asia, and the US, with over 65% of revenue from China.
- Company typePublic
- Founded2021
- HeadquartersSilverwater, Australia
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What EZZ Life Science Holdings does
EZZ Life Science Holdings Limited (ASX: EZZ) is an Australian genomic life sciences company headquartered in Lidcombe, NSW, that develops, produces, and distributes consumer health supplements and wellness products. The company operates across three sub-brands: the core EZZ range (51+ health supplements spanning genetic longevity, HPV support, H. pylori digestive health, weight management, and children's health), the MeTime women's wellness range launched May 2026, and EZZDAY, a US-market brand with FDA-registered products launched in 2025. EZZ is also the exclusive distributor of EAORON premium skincare products in Australia and New Zealand.
The underlying product development rests on genomic research across four focus areas (genetic longevity, HPV, H. pylori, and weight management), partnerships with ingredient suppliers such as Italian botanical specialist Bionap (Morosil, validated in a 102-volunteer 6-month RCT), TGA-registered product listings, GMP manufacturing standards, and a University of Auckland research collaboration. US-market production is handled by an FDA-approved pharmaceutical contract manufacturer in Los Angeles.
EZZ monetizes primarily through one-time product sales of branded health supplements, with more than 65% of revenue derived from China via digital channels (JD Health, Douyin, Kuaishou, Tmall), supported by enterprise field-sales relationships, distributor agreements with minimum purchase commitments (Aumake: $10M over 4 years; ROFA: $21M over 3 years), and pharmacy/retail partnerships (Chemist Warehouse, Watsons, DFS duty-free). The company reports nil external debt, ~$20.8M cash reserves, and pays dividends; FY23 revenue was $37.1M AUD (+147.3% YoY) with $4.8M EBITDA, and H1 FY25 showed a 40% revenue lift with a threefold profit increase.
EZZ Life Science Holdings firmographics
Firmographics- Name
- EZZ Life Science Holdings
- Legal name
- EZZ Life Science Holdings Limited
- Website
- https://ezzlife.com.au
- Company type
- Public
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EZZ Life Science Holdings (ASX: EZZ) is an Australian genomic life sciences company that develops, produces, and distributes consumer health supplements and wellness products under the EZZ, MeTime, and EZZDAY brands across Australia, China, Southeast Asia, and the US, with over 65% of revenue from China.
- Ownership category
- akta.pro rank
EZZ Life Science Holdings industry classification
Industry- Product category
- Consumer Health Supplements / Nutraceuticals
- NAICS
- Food (Health) Supplement Retailers (456191), Health and Personal Care Retailers (456)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
- akta.pro secondary industries
- Weight Management & Metabolic Supplements (CRADAGAG), Women’s Health Supplements (Prenatal, Menopause, Hormonal) (CRADAGAK), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Men’s Health Supplements (Testosterone, Prostate, Vitality) (CRADAGAL), Better-for-You / Functional Snacks (Low Sugar, Keto, Probiotic, Fortified) (CRADABAM)
Keywords
Where EZZ Life Science Holdings is headquartered
LocationHeadquarters
- HQ city
- Silverwater
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
EZZ Life Science Holdings business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Marketing or Sales, Technology or R&D, Personnel, Operations
Revenue model
- Health supplement sales: EZZ formulates, produces, markets, and distributes health supplements under the EZZ brand throughout Asia and other global markets. The company invests in R&D with third-party partners to develop products for strong market positions. More than 65% of EZZ's revenue comes from China.
- EAORON skincare distribution: EZZ is the exclusive distributor of EAORON premium skincare solutions in Australia and New Zealand, distributing to pharmacies, supermarkets, and specialist retailers.
- JD Health platform distribution: EZZ distributes and promotes its premium health supplement range via JD Health's platform, tapping into its large user base, integrated supply chain, and digital healthcare ecosystem. Collaboration across product launches, digital marketing campaigns, and customer acquisition initiatives.
- Aumake global distribution: Four-year global distribution agreement with Aumake for co-developed EZZ-branded products. Minimum purchase commitments of $10 million over the initial term and $2.5m annually. Aumake appointed as exclusive global distributor across all channels.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | EZZ Hair Protector available at Chemist Warehouse |
Go-to-market motion4 records
Distribution channels9 records
Marketing channels6 records
EZZ Life Science Holdings product offering
Product offeringCore offering
EZZ Life Science Holdings is a genomic life sciences company that develops, produces, markets, and distributes branded health supplements and wellness products, with a portfolio spanning genetic longevity, HPV support, Helicobacter pylori digestive health, weight management, gut microbiome, women's wellness (MeTime range), children's health, haircare, and men's health. The company operates the EZZ brand, the MeTime functional wellness sub-brand, the EZZDAY US sub-brand with FDA-registered products, and is the exclusive distributor of EAORON premium skincare products in Australia and New Zealand.
Product overview
EZZ Life Science Holdings is a genomic life sciences company that develops, produces, markets, and distributes health and wellness products across multiple categories. The company operates primarily through its EZZ brand of health supplements (including health supplements, functional foods, haircare, children's health, and probiotics) and as the exclusive distributor of EAORON premium skincare products in Australia and New Zealand. The EZZ product portfolio spans bone growth (Bone Growth Chews), digestive health (EnGastro, HHP biotic products targeting IBS and Helicobacter pylori), weight management (Hunger Helper with Morosil and Reducose), women's wellness (MeTime functional wellness range with Muscle Relief Magnesium and Corti-Calm), men's health, haircare, and children's health. For the US market, the company launched the EZZDAY sub-brand featuring FDA-registered supplements targeting digestive health, women's wellness, detox, and anti-ageing. Products are distributed through omnichannel strategies spanning Australia, New Zealand, China (via Douyin, Tmall, Kuaishou, JD Health), Southeast Asia, and the United States.
Differentiator
Problem solved
Functional benefit
Brands
- MeTime: Multi-product women's wellness range targeting stress, sleep, metabolism, and hormonal balance featuring products such as Hunger Helper, Muscle Relief Magnesium, and Corti-Calm
- EZZDAY
- EAORON
Products and services
- EZZ Brand Health Supplements Comprehensive range of EZZ-branded genomic-research-backed health and wellness supplements spanning genetic longevity, HPV support, Helicobacter pylori digestive health, weight management, gut health, hormonal balance, children's health, men's performance, brain focus, and haircare. Targeted at individual consumers across Australia, China, Southeast Asia, and more than 20 countries.
- EAORON Skincare (Exclusive ANZ Distribution)
Quantifiable outcome
- 147.3% revenue growth in FY23 reaching $37.1 million
- +5 more outcomes
Companies that use EZZ Life Science Holdings
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles4 records
EZZ Life Science Holdings technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
EZZ Life Science Holdings partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, major and minor.
- BionapcoreEZZ entered a formal ingredient partnership with Bionap, an Italian botanical extract specialist with more than 30 years of research and production expertise. Bionap is recognized for patented, standardized plant extracts and commitment to sustainability, traceability, and quality certification. Research portfolio focuses on healthy ageing and key health domains including metabolism, cognition, gut health, and cardiovascular function. One featured ingredient is Morosil, a patented extract from Moro blood oranges that has been clinically evaluated in a randomized, double-blind, placebo-controlled trial.
- JD HealthcoreStrategic cooperation framework with JD Health (subsidiary of JD.com, listed on Hong Kong Stock Exchange) for distribution and promotion of EZZ's premium health supplement range via JD Health's platform. JD Health operates one of China's largest online healthcare ecosystems spanning pharmaceuticals, supplements, medical services, and digital health solutions. Collaboration across product launches, digital marketing campaigns, customer acquisition initiatives, and logistics and service delivery enhancements.
- AumakecoreFour-year global distribution agreement with Aumake for co-developed EZZ-branded products. Aumake (ASX: AUK) appointed as exclusive global distributor across all channels. Includes minimum purchase commitments of $10 million over initial term and $2.5 million annually. Failure to meet annual or aggregate minimum sales thresholds may result in termination of exclusive distribution rights. EZZ retains full ownership of all intellectual property and maintains oversight of product integrity, branding, and compliance.
- ROFA EnterprisesmajorThree-year $21 million distribution deal with ROFA Enterprises for sale of EZZ-branded healthcare products across Thailand, Vietnam, and Singapore. Agreement supports EZZ's expansion into Southeast Asian markets where consumer preferences share similarities with China.
- Australian OpencoreThree-year regional sponsorship deal beginning 2025 for EZZ to be wellness and supplements sponsor for China and Southeast Asia. Company logo digitally enhanced on court-side advertising for regional viewers. More than 300 million Chinese fans expected to watch the Australian Open. Sponsorship brings key Chinese and Southeast Asian influencers and distributors to the Australian Open.
- Asia Pacific Aviator ClubminorAdvertising partnership with Asia Pacific Aviator Club featuring EZZ and EAORON branding across 2 million boarding passes of airlines including Air China, China Southern Airlines, China Eastern Airlines, Sichuan Airlines, Xiamen Airlines, and Hainan Airlines. Exclusive products also offered across APAC online shopping mall.
- Alibaba GroupmajorEZZ participates in Alibaba's e-commerce ecosystem including Tmall Global, Alibaba E-Commerce Expo events, and business matching programs. The company leverages Alibaba platforms for cross-border e-commerce into China. EZZ has been recognized as a top Australian brand on Alibaba platforms during major shopping events like 11.11 (Singles' Day).
- DFS (Duty Free Stores)minorDFS partnership allows EZZ products to be sold at DFS Auckland International Airport store and DFS flagship Sydney store. Seven premium products including EAORON hydration and anti-aging solutions and EZZ Bone Growth Chews available for Chinese tourists.
- HIC (Aubay Pty. Ltd.)minorTwo-year partnership with HIC (Aubay Pty. Ltd.) for social e-commerce distribution. HIC services more than three million consumers across 27 countries including China, UK, and USA. Partnership provides unique opportunity for EZZ products to reach consumers outside existing distribution channels.
- University of AucklandminorResearch agreement with University of Auckland to conduct product research, supporting EZZ's genomic health focus and product development pipeline.
- WatsonsmajorEZZ established strategic partnership with Watsons, a healthcare and beauty chain store in Asia and Europe with 400 stores in China already selling EZZ products.
Scale indicators14 records
Recent moves8 records
Expansion highlights6 records
EZZ Life Science Holdings competitors and assessment
Company assessmentBroad incumbents
- Nature's Way: Established North American vitamins and supplements brand owned by Schwabe Group. Comparable in clinically-backed botanical/probiotic product portfolio and global pharmacy distribution, though at much greater scale.
- Bayer Consumer Health: Global consumer health division of Bayer, owner of brands like Elevit, Berocca, and One A Day. Comparable in pharmacy-channel vitamins and women's/men's health products, particularly in Australian and Asian markets.
- GNC Holdings: US-based global specialty retailer and manufacturer of health and wellness products including vitamins and supplements. Comparable in product mix, and a relevant peer for EZZDAY's US expansion strategy.
- Herbalife Nutrition: Global nutrition company with deep MLM-driven distribution and a significant Asia-Pacific / China presence. Comparable in nutritional supplement portfolio and consumer-facing health/wellness positioning.
- Sanofi Consumer Healthcare: Global consumer healthcare business of Sanofi including vitamins and supplements brands. Comparable as a broad incumbent in the pharmacy-supplement category, with global regulatory and distribution scale that contrasts with EZZ's emerging-market position.
Direct peers
- Pharmacare Laboratories: Australian private company behind Nature's Own, Cenovis, and Bio Organics supplement brands. Directly comparable in product portfolio, pharmacy channel presence (Chemist Warehouse) and Australian consumer targeting.
- Blackmores Limited: Australia's largest listed vitamins and supplements brand (ASX:BKL), serving Asia-Pacific with a comparable premium, science-backed positioning. Direct competitor in Australian pharmacy channels and Asia consumer markets where EZZ derives most of its revenue.
- BYHEALTH (汤臣倍健): China's largest vitamins and dietary supplements company (300901.SZ). Direct competitor for EZZ's Chinese consumer base with comparable product categories (probiotics, weight management, women's health) and major Tmall/Douyin presence.
- Jamieson Wellness: Canadian manufacturer of vitamins, minerals, and supplements (TSX:JWEL). Comparable in branded supplements with cross-border China/Asia distribution and focus on quality/regulatory certifications (NPN, GMP).
- Swisse Wellness (H&H Group): Premium Australian supplements brand now owned by Health and Happiness International (HKEX). Competes head-to-head in Australian pharmacy and Chinese cross-border e-commerce, with similar celebrity/influencer-driven marketing and premium positioning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
EZZ Life Science Holdings social profiles
Digital presenceEZZ Life Science Holdings financial estimates
Financial estimateRevenue estimate
Valuation estimate
EZZ Life Science Holdings leadership team
Management profileNumber of profiles
Profiles10 records
EZZ Life Science Holdings subsidiaries and ownership
Company hierarchySubsidiaries1 record
EZZ Life Science Holdings funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EZZ Life Science Holdings M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EZZ Life Science Holdings
What does EZZ Life Science Holdings do?
EZZ Life Science Holdings is a genomic life sciences company that develops, produces, markets, and distributes branded health supplements and wellness products, with a portfolio spanning genetic longevity, HPV support, Helicobacter pylori digestive health, weight management, gut microbiome, women's wellness (MeTime range), children's health, haircare, and men's health. The company operates the EZZ brand, the MeTime functional wellness sub-brand, the EZZDAY US sub-brand with FDA-registered products, and is the exclusive distributor of EAORON premium skincare products in Australia and New Zealand.
Is EZZ Life Science Holdings a public or private company?
EZZ Life Science Holdings is a public company. It is classified as public and is currently operating.
When was EZZ Life Science Holdings founded?
EZZ Life Science Holdings was founded in 2021. It employs 11 to 50 people.
Where is EZZ Life Science Holdings based?
EZZ Life Science Holdings is headquartered in Silverwater, Australia, in the Oceania region.
How does EZZ Life Science Holdings make money?
Four revenue lines are on record. Health supplement sales are the primary driver. The others are EAORON skincare distribution, JD Health platform distribution and aumake global distribution.
Who are EZZ Life Science Holdings's main competitors?
Broad incumbents on record are Nature's Way, Bayer Consumer Health, GNC Holdings, Herbalife Nutrition and Sanofi Consumer Healthcare. Direct peers are Pharmacare Laboratories, Blackmores Limited, BYHEALTH (汤臣倍健), Jamieson Wellness and Swisse Wellness (H&H Group).
Does EZZ Life Science Holdings have an API?
No public API is recorded for EZZ Life Science Holdings.
What industry is EZZ Life Science Holdings in?
EZZ Life Science Holdings's product category is Consumer Health Supplements / Nutraceuticals. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of CRADAGAG, Weight Management & Metabolic Supplements. Its NAICS code is 456191 and its SIC code is 5122.